Cargando…
Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using (64)Cu-labeled antibodies in a neuroblastoma mouse model
Antibody-based therapies gain momentum in clinical therapy, thus the need for accurate imaging modalities with respect to target identification and therapy monitoring are of increasing relevance. Cerenkov luminescence imaging (CLI) are a novel method detecting charged particles emitted during radioa...
Autores principales: | Maier, Florian C., Schmitt, Julia, Maurer, Andreas, Ehrlichmann, Walter, Reischl, Gerald, Nikolaou, Konstantin, Handgretinger, Rupert, Pichler, Bernd J., Thaiss, Wolfgang M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341884/ https://www.ncbi.nlm.nih.gov/pubmed/27602580 http://dx.doi.org/10.18632/oncotarget.11795 |
Ejemplares similares
-
Cerenkov Luminescence Tomography for In Vivo Radiopharmaceutical Imaging
por: Zhong, Jianghong, et al.
Publicado: (2011) -
Intrinsically Radioactive [(64)Cu]CuInS/ZnS Quantum Dots for PET and Optical Imaging: Improved Radiochemical Stability and Controllable Cerenkov Luminescence
por: Guo, Weisheng, et al.
Publicado: (2014) -
PEGylated crushed gold shell-radiolabeled core nanoballs for in vivo tumor imaging with dual positron emission tomography and Cerenkov luminescent imaging
por: Lee, Sang Bong, et al.
Publicado: (2018) -
Endoscopic imaging of Cerenkov luminescence
por: Kothapalli, Sri-Rajasekhar, et al.
Publicado: (2012) -
Ex Vivo Model of Neuroblastoma Plasticity
por: Schäfer, Paula, et al.
Publicado: (2023)